The global radiopharmaceuticals market is expected to grow from USD 7.82 billion in 2026 to USD 13.78 billion by 2036, driven by rising cancer prevalence, expanding nuclear medicine infrastructure, and advances in precision oncology.

Quintile Reports projects strong growth in the global EUV pellicle market, driven by rising adoption of EUV lithography, AI chips, and advanced semiconductor manufacturing technologies through 2036.